The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) — Massimo Filippi (2023) | RDL Network
Erenumab modulates RS FC of networks involved in migraine pathophysiology. In line with clinical response, erenumab-induced brain RS FC changes tend to reverse when treatment is stopped.
Else Eising, Sjoerd M. H. Huisman, Ahmed Mahfouz, Lisanne S. Vijfhuizen, Verneri Anttila, Bendik S. Winsvold, Tobias Kurth, M. Arfan Ikram, Tobias Freilinger, Jaakko Kaprio, Dorret I. Boomsma, Cornelia M. van Duijn, Paul M Ridker, John‐Anker Zwart, Lydia Quaye, David P. Strachan, Christian Kubisch, Martin Dichgans, George Davey Smith, Kāri Stefánsson, Aarno Palotie, ,
Discussion(0)
No comments yet. Be the first to comment.